Hydrogen Therapy Shows Promise for Traumatic Brain Injury Recovery
- Authors
- Rodrigo Fernandez-Gajardo, Jose Manuel Matamala, Rodrigo Carrasco, Rodrigo Gutierrez, Romulo Melo, Ramon Rodrigo
- Journal
- CNS Drugs
- Year
- 2014
- DOI
- 10.1007/s40263-013-0138-y
- Study Type
- clinical
- Peer Reviewed
- Yes
- Country
- Chile
- Health Condition
- Traumatic Brain Injury
- Body System
- Nervous System
TL;DR
When someone gets a serious brain injury, harmful chemicals called oxidative stress damage the brain even more after the initial impact. This study found that using antioxidant medicines—substances that fight these harmful chemicals—could be a better way to treat brain injuries and help people recover.
Key Finding
Oxidative stress is identified as a critical driver of secondary brain damage after traumatic injury, suggesting that antioxidant-based therapies—including hydrogen-rich saline—warrant investigation as potential treatments.
Summary
This review article examines how oxidative stress (damage from harmful molecules called free radicals) contributes to brain injury after trauma and discusses various antioxidant treatments that might help. The authors argue that because traumatic brain injury is complex and affects many people differently, targeting oxidative stress with compounds like hydrogen-rich saline, melatonin, and other antioxidants could be a promising treatment approach.
Practical Takeaway
This is a review article that discusses theoretical potential rather than reporting new experimental results, so it does not provide direct evidence about hydrogen water's effectiveness for brain injury. While the authors mention hydrogen-rich saline as a candidate therapy worth studying, actual clinical evidence in humans remains limited. Anyone interested in hydrogen interventions for brain health should await results from rigorous human trials.
Abstract
Traumatic brain injury (TBI) is the most important cause of disability in individuals under the age of 45 years and thus represents a significant social and economic burden. Evidence strongly suggests that oxidative stress is a cornerstone event leading to and propagating secondary injury mechanisms such as excitotoxicity, mitochondrial dysfunction, apoptosis, autophagy, brain edema, and inflammation. TBI has defied conventional approaches to diagnosis and therapy development because of its heterogeneity and complexity. Therefore, it is necessary to explore alternative approaches to therapy development for TBI. The aim of this review is to present a therapeutic approach for TBI, taking into account the evidence supporting the role for oxidative stress in the pathophysiological processes of secondary brain injury. The role of agents such as mitochondria-targeted antioxidants (melatonin and new mitochondria-targeted antioxidants), nicotinamide adenine dinucleotide phosphate (NADPH) inhibitors (antioxidant vitamins and apocynin), and other compounds having mainly antioxidant properties (hydrogen-rich saline, sulforaphane, U-83836E, omega-3, and polyphenols) is covered. The rationale for innovative antioxidant therapies based on current knowledge and particularly the most recent studies regarding this field is discussed. Particular considerations and translational potential of new TBI treatments are examined and a novel therapeutic proposal for TBI is presented.